A review of the influence of aqueous humor on immunity

References

• Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol. 1977;25:1–54.
   PubMed Web of Science ®Google Scholar
• Medawar P. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29:58–69.
   Google Scholar
• Taylor AW. Neuroimmunomodulation in immune privilege: role of neuropeptides in ocular immunosuppression (Revised). Neuroimmunomodulation. 2002;10: 189–198.
   PubMed Web of Science ®Google Scholar
• Taylor AW. Ocular immunosuppressive microenvironment. Chem Immunol. 1999;73:72–89.
   PubMedGoogle Scholar
• Streilein JW. Immunoregulatory mechanisms of the eye. Prog Retin Eye Res. 1999;18:357–370.
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Immune privilege in the anterior chamber of the eye. Grit Rev Immunol. 2002;22:13–46.
   PubMed Web of Science ®Google Scholar
• Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994;153:1080–1086.
   Google Scholar
• Taylor AW, Yee DG. Somatostatin is an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 2003;44:2644–2649.
   PubMed Web of Science ®Google Scholar
• Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199–1206.
   Google Scholar
• Star RA, Rajora N, Huang J, et al. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA. 1995;92:8016–8020.
   PubMed Web of Science ®Google Scholar
• Taylor AW, Yee DG, Streilein JW. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci. 1998;39:1372–1378.
   Google Scholar
• Caspi RR, Sun B, Agarwal RK, et al. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye. 1997; ii\(Pt 2):209–212.
   Google Scholar
• Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol. 1987;138:3688–3694.
   Google Scholar
• Buchanan KL, Murphy JW. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology. 1997;90:189–197.
   PubMed Web of Science ®Google Scholar
• Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol. 1998;16:201–223.
   PubMed Web of Science ®Google Scholar
• Kaiser CJ, Ksander BR, Streilein JW. Inhibition of lymphocyte proliferation by aqueous humor. Reg Immunol. 1989;2:42–49.
   Google Scholar
• Cousins SW, Trattler WB, Streilein JW. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr Eye Res. 1991;10:287–297.
   Google Scholar
• Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol. 1990;144:3021–3027.
   PubMed Web of Science ®Google Scholar
• Cousins SW, McCabe MM, Danielpour D, et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201–2211.
   PubMed Web of Science ®Google Scholar
• Taylor AW. Immunoregulation of the ocular effector responses by soluble factors in aqueous humor. Reg Immunol. 1994;6:52–57.
   Google Scholar
• Taylor AW, Alard P, Yee DG, et al. Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr Eye Res. 1997;16:900–908.
   PubMed Web of Science ®Google Scholar
• Nishida T, Taylor AW. Specific aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci. 1999;40: 2268–2274.
   PubMed Web of Science ®Google Scholar
• Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207–214.
   PubMed Web of Science ®Google Scholar
• Taylor A, Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol. 2001;79:358–367.
   PubMed Web of Science ®Google Scholar
• Namba K, Kitaichi N, Nishida T, et al. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukocyte Biol. 2002;72:946–952.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–680.
   Google Scholar
• Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett. 2003;85:85–95.
   PubMed Web of Science ®Google Scholar
• Akira S. Mammalian toll-like receptors. Curr Opin Immunol. 2003;15:5—I I.
   Google Scholar
• Schnare M, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2001;2: 947–950.
   PubMed Web of Science ®Google Scholar
• Qi H, Denning TL, Soong L. Differential induction of interleukin-io and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect Immun. 2003;71: 3337–3342.
   Google Scholar
• Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD 14., TLRs and the LPS-activation cluster. Trends Immunol. 2002;23: 301–304.
   Google Scholar
• Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem. 2001; 276:37692–37699.
   PubMed Web of Science ®Google Scholar
• Taylor AW, Streilein JW, Cousins SW. Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation. 1994; 1:188–194.
   Google Scholar
• Streilein JW, Mash S, Takeuchi M, et al. The eye's view of antigen presentation. Hum Immunol. 2002; 63:435–443.
   PubMed Web of Science ®Google Scholar
• Wilbanks GA, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol. 1992;22:1031–1036.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Alard P, Verbik D, et al. Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis. Immunology. 1999;98:576–583.
   PubMed Web of Science ®Google Scholar
• Mash S, Turpie B, Hecker KH, et al. Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J Immunol. 2002;168:2264–2273.
   PubMed Web of Science ®Google Scholar
• Liu Y, Dana MR, Tewari V, et al. Immune response to intragraft antigen in draining lymph nodes after corneal transplantation is mediated by interleukin-12. J Interferon Cytokine Res. 2001;21: 813–819.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med. 2002;195:259–268.
   PubMed Web of Science ®Google Scholar
• Perez VL, Biuckians AJ, Streilein JW. In-vivo impaired T helper i cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye. Ocu/ Immunol Inflamm. 2000;8: 9–24.
   Google Scholar
• Haynes RJ, McElveen JE, Dua HS, et al. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 2000;41: 3026–3031.
   PubMed Web of Science ®Google Scholar
• Mc NN, Van R, Tuchin OS, et al. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69:483–490.
   PubMed Web of Science ®Google Scholar
• Lehmann OJ, Hussain IR, Watt PJ. Investigation of beta defensin gene expression in the ocular anterior segment by semiquantitative RT-PCR. Br J Ophthalmol. 2000;84: 523–526.
   Google Scholar
• McDermott AM, Redfern RL, Zhang B, et al. Defensin expression by the cornea: multiple signalling pathways mediate IL-Ibeta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 200344:1859-1865.
   PubMed Web of Science ®Google Scholar
• Uchio E, Kijima M, Ishioka M, et al. Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells. Graefes Arch Guth Exp Ophthalmol. 1997;235:97–102.
   PubMed Web of Science ®Google Scholar
• Taylor AW, Yee DG, Nishida T, et al. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann NY Acad Sci. 2000;917:239–247.
   Google Scholar